Visitors at this page also visited
The Haemophilus influenzae type B vaccine, often called Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b (Hib) infection. In countries that include it as a routine vaccine, rates of severe Hib infections have decreased more than 90%. It has therefore resulted in a decrease in the rate of meningitis, pneumonia, and epiglottitis. It is given by injection into a muscle.Severe side effects are uncommon. About 20 to 25% of people develop pain at the site of injection while about 2% develop a fever.There is no clear association with severe allergic reactions. The Hib vaccine is available by itself, in combination with the diphtheria/tetanus/pertussis vaccine, and in combination with the hepatitis B vaccine, among others.All Hib vaccines that are currently used are conjugate vaccine. An initial Hib vaccine was developed in 1977 which was replaced by a more effective formulation in the 1990s.As of 2013, 184 countries include it in their routine vaccinations. (source)
Similar pages on this site
Good to know
Predict The Future: the prediction that will save the world, and predict Ebola outbreaks
Dr. Kira Radinsky, TEDMED
Read how smart choices save lives.
Even when genetic variation directly influences our IQ as well as our health.
After Doctors Cut Their Opioids, Patients Turn to a Risky Treatment for Back Pain
Sheila Kaplan, The New York Times